+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Antihyperlipidemic Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Antihyperlipidemic Drugs Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
From
Heart Failure Drugs Market 2021-2025 - Product Thumbnail Image

Heart Failure Drugs Market 2021-2025

  • Report
  • January 2022
  • 120 Pages
  • Global
From
From
From
Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Enhancer Of Zeste Homolog 2 Protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
ACVR1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACVR1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Japan Healthcare Outlook Report, 2022 - Product Thumbnail Image

Japan Healthcare Outlook Report, 2022

  • Report
  • January 2022
  • 60 Pages
  • Japan
From
Gastrointestinal Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Gastrointestinal Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
Loading Indicator